ZYUS Life Sciences's market cap is currently ―. The company's EPS TTM is C$-0.52; its P/E ratio is ―; ZYUS Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 123.00K	$ 118.00K	$ 114.00K	$ 97.00K	$ 99.00
Gross Profit	$ 71.00K	$ 64.00K	$ 58.00K	$ 62.00K	$ 53.00
EBIT	$ -3.61M	$ -4.65M	$ -3.17M	$ -32.60M	$ -4.00K
EBITDA	$ -2.89M	$ -3.92M	$ -2.45M	$ -29.49M	$ -3.23K
Net Income Common Stockholders	$ -3.92M	$ -4.81M	$ -3.34M	$ -21.74M	$ -4.19K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 346.00K	$ 836.00K	$ 2.55M	$ 5.85M	$ 9.11K
Total Assets	$ 33.98M	$ 35.79M	$ 38.22M	$ 41.63M	$ 71.83K
Total Debt	$ 7.94M	$ 10.16M	$ 9.86M	$ 9.81M	$ 10.87K
Net Debt	$ 7.59M	$ 9.32M	$ 7.31M	$ 3.95M	$ 1.75K
Total Liabilities	$ 19.09M	$ 20.26M	$ 18.15M	$ 18.51M	$ 25.10K
Stockholders Equity	$ 14.89M	$ 15.53M	$ 20.07M	$ 23.11M	$ 46.73K
Cash Flow	-
Free Cash Flow	$ -1.51M	$ -443.00K	$ -2.67M	$ -18.28M	$ -14.99K
Operating Cash Flow	$ -1.50M	$ -443.00K	$ -2.64M	$ -18.00M	$ -14.96K
Investing Cash Flow	$ -11.00K	-	$ -34.00K	$ 4.64M	$ 6.64K
Financing Cash Flow	$ 931.00K	$ 357.00K	$ -341.00K	$ 17.12M	$ -875.00

Currency in USD

ZYUS Life Sciences Earnings and Revenue History

Income Statement >

ZYUS Life Sciences Debt to Assets

Balance Sheet >

ZYUS Life Sciences Cash Flow

Cash Flow >

ZYUS Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing